Clinton Group’s Cantel Medical Corporation CMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-35,133
Closed -$3.46M 420
2018
Q2
$3.46M Buy
35,133
+33,332
+1,851% +$3.73M 0.54% 55
2018
Q1
$201K Buy
+1,801
New +$202K 0.02% 342
2017
Q2
Sell
-15,475
Closed -$1.24M 959
2017
Q1
$1.24M Buy
15,475
+8,206
+113% +$652K 0.07% 376
2016
Q4
$572K Buy
+7,269
New +$565K 0.03% 535
2016
Q3
Sell
-7,720
Closed -$531K 1113
2016
Q2
$531K Buy
+7,720
New +$533K 0.02% 629

Other funds holding CMD

Clinton Group's CMD Position: Q3 2018 in Review

Clinton Group sold out of Cantel Medical Corporation (CMD) in Q3 2018, closing a stake of 35,133 shares — an estimated $3.46M sold.

Clinton Group first reported a position in CMD in Q2 2016 and held it in 5 quarters. The position peaked at $3.46M in Q2 2018. 286 funds tracked by Wall St. Rank hold CMD as of Q3 2018.

  • Clinton Group reported no remaining Cantel Medical Corporation position as of Q3 2018 after selling out during the quarter.
  • Clinton Group sold 35,133 Cantel Medical Corporation shares in Q3 2018, an estimated $3.46M.
  • Clinton Group first reported a position in Cantel Medical Corporation in Q2 2016 and held it in 5 quarters.
  • Clinton Group's Cantel Medical Corporation position peaked at $3.46M in Q2 2018.
  • 286 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q3 2018.

Based on Clinton Group's 13F filing for Q3 2018, filed 10 Oct 2018.